RISPOLI, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 216
AS - Asia 136
NA - Nord America 110
SA - Sud America 23
AF - Africa 1
Totale 486
Nazione #
US - Stati Uniti d'America 108
IT - Italia 82
SG - Singapore 78
RU - Federazione Russa 60
DE - Germania 32
HK - Hong Kong 23
BR - Brasile 21
CN - Cina 21
FI - Finlandia 13
ES - Italia 7
NL - Olanda 7
IE - Irlanda 6
IN - India 5
AT - Austria 4
IR - Iran 4
CO - Colombia 2
IQ - Iraq 2
KR - Corea 2
UA - Ucraina 2
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
LU - Lussemburgo 1
MX - Messico 1
PA - Panama 1
SE - Svezia 1
TR - Turchia 1
Totale 486
Città #
Singapore 25
Chandler 24
Hong Kong 23
Munich 17
Moscow 15
Princeton 11
Ashburn 10
Naples 10
Turku 10
Beijing 7
Würselen 7
Ann Arbor 6
Boardman 6
Domicella 6
Fisciano 6
Nuremberg 5
Sarno 5
Dallas 4
Dublin 4
Los Angeles 4
Rome 4
Afragola 3
Castelfranco in Miscano 3
Manocalzati 3
Pune 3
Tehran 3
Wilmington 3
Arzano 2
Atlanta 2
Baghdad 2
Cava de' Tirreni 2
Helsinki 2
Salerno 2
Seattle 2
The Dalles 2
Trento 2
Vienna 2
Abidjan 1
Acerra 1
Amsterdam 1
Andover 1
Ankara 1
Aracaju 1
Arcoverde 1
Aversa 1
Bari 1
Bastrop 1
Brno 1
Calçado 1
Carapicuíba 1
Carinola 1
Catalão 1
Chennai 1
Concord 1
Contagem 1
Criciúma 1
Curvelo 1
Florianópolis 1
Fredericksburg 1
Garça 1
Hanover 1
Houston 1
Imbituba 1
Istra 1
Jacksonville 1
Jiaxing 1
Jinan 1
Joinville 1
Lappeenranta 1
Levittown 1
Luxembourg 1
Milan 1
Montano Antilia 1
New York 1
Nola 1
Panama City 1
Patna 1
Phoenix 1
Pitimbu 1
Pouso Alegre 1
Puebla City 1
Quibdó 1
Recale 1
Recife 1
San Antonio 1
San Diego 1
San Francisco 1
San Jose 1
Sete Lagoas 1
Sochi 1
Stockholm 1
São João de Meriti 1
São Paulo 1
Tubarão 1
Tunja 1
Votorantim 1
Wuxi 1
Xi'an 1
Yangzhou 1
Yubileyny 1
Totale 310
Nome #
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 74
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 64
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy) 56
589 THE EFFECT OF DAPAGLIFLOZIN ON SYMPTOMS, QUALITY OF LIFE AND ECHOCARDIOGRAPHIC PARAMETERS IN A REAL-WORLD POPULATION OF HFREF PATIENTS 46
The favourable alliance between cardiomems and levosimendan in patients with advanced heart failure 37
Vitamin D: A Bridge between Kidney and Heart. 33
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 32
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019 30
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 29
An explainable model for predicting Worsening Heart Failure based on genetic programming 28
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 23
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 20
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 16
Wearable Technologies and AI at the Far Edge for Chronic Heart Failure Prevention and Management: A Systematic Review and Prospects 14
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 10
Totale 512
Categoria #
all - tutte 2.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 1 0 3 6 0 0 3 2 1 3 1
2021/202225 0 0 0 0 0 0 12 2 1 1 1 8
2022/202359 3 7 15 7 3 8 0 8 3 1 2 2
2023/202495 1 2 6 2 11 13 4 5 0 6 3 42
2024/2025308 4 3 2 14 14 21 72 15 63 8 41 51
Totale 512